# ANTIVIRAL DRUG DEVELOPMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION

> **NIH NIH N43** · ZYMERON CORPORATION · 2020 · $300,000

## Abstract

To develop a therapeutic that will effect a functional cure of chronic hepatitis B.

## Key facts

- **NIH application ID:** 10267594
- **Project number:** 75N93020C00047-0-9999-1
- **Recipient organization:** ZYMERON CORPORATION
- **Principal Investigator:** FANG LIU
- **Activity code:** N43 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $300,000
- **Award type:** —
- **Project period:** 2020-08-21 → 2021-08-20

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10267594

## Citation

> US National Institutes of Health, RePORTER application 10267594, ANTIVIRAL DRUG DEVELOPMENT FOR CHRONIC HEPATITIS B VIRUS INFECTION (75N93020C00047-0-9999-1). Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/grant/nih/10267594. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*